Paper Details
- Home
- Paper Details
Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
Author: BergerM, BraunJ S, GeigerR, SchäfferS, WehnerH
Original Abstract of the Article :
There are few published reports of antidepressive therapy induced hepatotoxicity. In most cases antidepressants cause only slight elevation of liver enzymes without clinical relevance. However, our patient with recidivation of unipolar depressive disorder developed severe laboratory abnormalities an...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1055/s-2007-979319
データ提供:米国国立医学図書館(NLM)
Hepatitis Linked to Antidepressant Therapy: A Rare Case
This case report explores the rare occurrence of hepatitis, a liver inflammation, caused by antidepressant therapy. It's like finding a strange oasis in the desert, where the expected greenery is replaced with something unexpected. The authors report a case where a patient developed severe liver abnormalities and symptoms while taking maprotiline and opipramol, two commonly used antidepressants. The patient's symptoms resolved after stopping the medication, highlighting the potential for these drugs to cause severe adverse effects. This study underscores the importance of careful monitoring and prompt intervention when patients experience unexplained symptoms during antidepressant therapy.
The Need for Vigilance
This case report emphasizes the need for vigilance in monitoring patients taking maprotiline and opipramol. While these drugs can be effective in treating depression, it's important to be aware of the potential for severe side effects, like encountering a hidden sandstorm on your journey through the desert. This study serves as a reminder that even seemingly safe medications can have unexpected consequences.
Patient Safety First
This study highlights the importance of patient safety and the need for comprehensive monitoring during antidepressant therapy. Doctors and patients must work together to ensure that any potential side effects are identified and addressed promptly. This study is a reminder that even with the best intentions, unexpected challenges can arise in the healthcare journey. It is essential to be vigilant and ready to adapt to new information.
Dr. Camel's Conclusion
This case report serves as a cautionary tale, highlighting the potential for even seemingly safe medications to cause serious side effects. Like a wise traveler in the desert, doctors and patients must be aware of the potential risks and prepared to adapt their course when necessary. Patient safety should always be the top priority, and vigilance is essential when navigating the complexities of healthcare.
Date :
- Date Completed 1998-12-03
- Date Revised 2016-11-24
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.